• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

2017 Fiscal Year Final Research Report

Role of SLURP-1, an endogenous alpha7 nicotinic acetylcholine receptor allosteric ligand, in T cell differentiation

Research Project

  • PDF
Project/Area Number 15K07969
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeMulti-year Fund
Section一般
Research Field Pharmacology in pharmacy
Research InstitutionKitasato University

Principal Investigator

Kawashima Koichiro  北里大学, 薬学部, 客員教授 (70095008)

Co-Investigator(Kenkyū-buntansha) 藤井 健志  同志社女子大学, 薬学部, 教授 (80255380)
間下 雅士  同志社女子大学, 薬学部, 助教 (30738886)
堀口 和秀  福井大学, 学術研究院医学系部門, 准教授 (20377451)
Co-Investigator(Renkei-kenkyūsha) MISAWA Hidemi  慶応大学, 薬学部, 教授 (80219617)
MORIWAKI Yasuhiro  慶応大学, 薬学部, 講師 (00392150)
Project Period (FY) 2015-04-01 – 2018-03-31
KeywordsnAChR / アロステリック・リガンド / Treg / Th1 / Th2 / GTS-21 / alpha7 / DO11.10マウス
Outline of Final Research Achievements

We studied roles of GTS-21, an alpha7 (a7) nAChR agonist, and recombinant human type SLURP-1 (rhSLURP-1), an endogenous allosteric a7 nAChR ligand, in regulation of T cell differentiation. The differentiation was activated by culturing spleen cells from DO11.10 mice with ovalbumin (OVA) or OVA peptide (OVA-P). The effects of GTS-21 and rhSLURP-1 on T cell differentiation into regulatory T cell (Tregs) and effector T cells (Th1 and Th2) were determined by FACS or ELISA. GTS-21 inhibited the differentiation into Tregs and effector T cells under OVA activation, but facilitated the differentiation under OVA-P activation. rhSLURP-1 did not show any effect under the present experimental conditions. These results suggest that a7 nAChR activation in antigen-presenting cells prevents antigen processing leading to suppression of the differentiation while a7 nAChR activation in T cell facilitates the differentiation. No effect with rhSLURP-1 may be due to species difference.

Free Research Field

薬理学

URL: 

Published: 2019-03-29  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi